Abivax S.A. | Mutual Funds
Mutual Funds that own Abivax S.A.
Amundi Actions PME
117,461
1.19%
0
0.09%
01/31/2018
Amundi Actions Restructurations
43,827
0.44%
0
0.06%
01/31/2018
Gestys Santé Biotech
20,000
0.2%
0
4.22%
03/23/2018
Lupus alpha Fonds - Micro Champions
20,000
0.2%
12,500
0.28%
12/31/2017
Lupus alpha Fonds - All Opportunities Fund
17,000
0.17%
0
0.11%
12/31/2017
Mirabaud - Equities France
13,890
0.14%
13,890
0.14%
06/30/2017
Aviva Investors Investment Funds ICVC - European Equity Fund
13,515
0.14%
-5,950
0.04%
10/15/2017
DekaLux - Mid Cap TF
7,923
0.08%
-76
0.04%
03/29/2018
Aviva Investors - European Equity Fund
7,807
0.08%
-1,870
0.03%
06/30/2018
Arcalis
300
0%
300
0%
12/31/2015
| Address |
5, rue de la Baume
Paris Ile-de-France 75008
France
|
|
Employees
|
- |
| Website |
http://www.abivax.com |
| Updated |
07/08/2019 |
| Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. |
